GlassScriptPhysician profile
Arthur S Clements
NPI 1033210778
$1,659.61
in general payments reported to CMS, 2019-2025
24 companies · $239 in 2025
The $239 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $458 · 2020: $123 · 2021: $153 · 2022: $73.51 · 2023: $389 · 2024: $224 · 2025: $239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $752 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $752.06 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $481.25 | 2019-2025 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $262.11 | 2019-2025 | Aptima, Acessa Provu System |
| Abbvie INC. | $164.95 | 2019-2023 | Liletta, Lo Loestrin Fe |
| Bayer Healthcare Pharmaceuticals INC. | $81.32 | 2019-2025 | |
| Millicent US INC | $69.39 | 2019-2025 | Intrarosa, Femring, Femlyv |
| Acella Pharmaceuticals, LLC | $64.64 | 2022-2025 | NP Thyroid 60 |
| Sumitomo Pharma America, INC. | $64.44 | 2023-2025 | Gemtesa, Myfembree |
| Roche Diagnostics Corporation | $63.62 | 2019-2020 | |
| Lupin INC. | $63.35 | 2019-2020 | |
| Therapeuticsmd, INC. | $35.24 | 2021-2022 | |
| Exeltis, USA INC. | $31.10 | 2023-2025 | Slynd |
| Glaxosmithkline, LLC. | $29.69 | 2019-2023 | Boostrix, Shingrix, Fluarix Quadrivalent |
| Lilly USA, LLC | $28.79 | 2024 | Zepbound |
| Coopersurgical, INC. | $28.12 | 2019-2022 | |
| Duchesnay USA Incorporated | $25.53 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $24.78 | 2019 | |
| Boston Scientific Corporation | $24.36 | 2025 | Axonics |
| Daiichi Sankyo INC. | $21.82 | 2019 | |
| Urovant Sciences INC | $17.53 | 2022 | |
| Asensus Surgical, INC. | $17.49 | 2019 | |
| Ethicon US, LLC | $16.89 | 2019 | |
| Medtronic, INC. | $15.60 | 2021 | |
| Davol INC. | $14.97 | 2019 | |
| Allergan, INC. | $12.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arthur Clements listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.